ESBATech is drug discovery company, exploiting its expertise in yeast technology for the development of therapeutic antibody fragments and the development of functional assays for small molecule screenings More
Founded in October 1999, Adjuvantix is using its specialist adjuvant technology to collaborate with vaccine companies to create a range of improved prophylactic vaccines and to develop novel therapeutic vaccines. More
In patenting, an originator tries to weave as strong and complex a web of protections as possible around a product while a potential copyist tries to find a way around or through that web More